Advanced Oncotherapy plans £37.4m fundraise

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy (AVO) has announced a £37.4m equity fundraise to bolster its balance sheet as it moves towards completing its next generation proton beam therapy system LIGHT with a 230MeV beam. The company, which is due to go live with the system by the end of this year, said the funds would be raised from…

You must be a HM Subscriber to view this content.

Subscribe Now »